(Q50887996)

24 March 2018

title

Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. (English)

1 reference

24 March 2018

1 reference

Ikeda Y

1

1 reference

24 March 2018

Suehiro T

2

1 reference

24 March 2018

Inoue M

3

1 reference

24 March 2018

Nakauchi Y

4

1 reference

24 March 2018

Morita T

5

1 reference

24 March 2018

Arii K

6

1 reference

24 March 2018

Ito H

7

1 reference

24 March 2018

Kumon Y

8

1 reference

24 March 2018

Hashimoto K

9

1 reference

24 March 2018

publication date

1 May 1998

1 reference

24 March 2018

published in

Metabolism

1 reference

24 March 2018

volume

47

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

598-602

1 reference

24 March 2018

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Is paraoxonase related to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

The oxidation hypothesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990246-3

10.1016/S0026-0495(98)90246-3

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018